Work Here?
Industries
AI & Machine Learning
Biotechnology
Company Size
51-200
Company Stage
Series C
Total Funding
$236.8M
Headquarters
Toronto, Canada
Founded
2014
Deep Genomics focuses on drug development in the biotechnology sector by utilizing artificial intelligence to explore RNA biology and discover potential therapies for genetic conditions. The company's main product, the AI Workbench, employs data-driven predictions to identify new drug targets. This tool has evolved over time, with versions that enhance its ability to target various genetic mechanisms and diseases. Deep Genomics differentiates itself from competitors by its specific focus on RNA splicing and its systematic approach to drug discovery, which includes licensing its findings to pharmaceutical companies and research institutions. The goal of Deep Genomics is to accelerate the drug development process and improve treatment options for patients suffering from genetic disorders.
Help us improve and share your feedback! Did you find this helpful?
Total Funding
$236.8M
Above
Industry Average
Funded Over
4 Rounds
Industry standards
Company Equity
Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Disability Insurance
Professional Development Budget
Deep Genomics, a Canadian biotech company, closed a $180 million Series C funding round led by Softbank, with investments from CPPIB, Fidelity, and others. The company, supported by Amplitude Ventures, uses AI to revolutionize drug discovery, focusing on RNA therapeutics. The funding will expand their AI workbench and pipeline, aiming to advance four programs into the clinic by 2023.
Newsletter Signup - Under Article / In Page"*" indicates required fields Precision medicine is a kind of treatment strategy that is tailored to individual patients, most of which is dependent on their genetic makeup. Genomics, which deals with the mapping of genomes, is a booming industry that aims to advance precision medicine to address a host of diseases. You may have heard of the big names in the business, like Illumina, Oxford Nanopore Technology, and Thermo Fisher Scientific. But there are a number of genomics startups that have sprouted up in the past decade or so to strengthen their sequencing technologies to aid in disease prevention and treatment. Here are seven genome sequencing startups that are making their mark in the industry.Element BiosciencesFounded in 2017, Element Biosciences shot to fame fairly quickly after the launch of its lab services. Its benchtop sequencing instrument AVITI has a dual flow cell layout and individually addressable lanes and you can perform two parallel runs and operate each side independently. Its alternative model, AVITI LT, is a lower-cost, lower-throughput solution that brings next-generation sequencing (NGS) to more labs.The core components of Element’s sequencing tool include an Avidite base chemistry, which circularizes, copies, and rolls each strand into tightly bound polonies – tiny clusters of identical DNA molecules – without the use of PCR and fluorescent avidites that bind to each polony creating ultrastable complexes. It also employs rolling circle amplification, which is a process that uses a circular DNA template to create long single-stranded DNA molecules to avoid errors such as index hopping – when sequencing reads are incorrectly assigned to the wrong sample in a pool. Its sought-after technology is called LoopSeq, which prepares libraries for long-read sequencing on the short-read Element AVITI System
For instance, Deep Genomics unveiled BigRNA, a pioneering AI foundation model for uncovering RNA biology and therapeutics.
Deep Genomics Inc. has introduced its artificial intelligence (AI) foundation model for RNA, BigRNA, which enables discovery of disease mechanisms and candidate therapeutics.
Deep Genomics introduces the most advanced AI Foundation model for RNA disease mechanisms and candidate therapeutics.
Find jobs on Simplify and start your career today
Industries
AI & Machine Learning
Biotechnology
Company Size
51-200
Company Stage
Series C
Total Funding
$236.8M
Headquarters
Toronto, Canada
Founded
2014
Find jobs on Simplify and start your career today